CSPC Pharmaceutical Group... (CSPCY)

PNK: CSPCY · Real-Time Price · USD

3.13

0.09 (2.96%)

At close: May 01, 2025, 3:59 PM

CSPC Pharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	12.02B	10.15B	11.36B	8.65B	4.82B	4.33B	4.38B	2.9B
Short-Term Investments	1.08B	3.52B	1.77B	1.82B	2.06B	2.29B	1.1B	466.5K
Long-Term Investments	4.64B	3.73B	4.42B	4.66B	1.83B	-1.39B	-743.52M	153.38M
Other Long-Term Assets	819.64M	553.73M	513.63M	421.34M	172.73M	2.62B	1.1B	466.51K
Receivables	10.51B	6.69B	7.98B	5.78B	4.92B	13.14M	2.58M	2.77B
Inventory	3.14B	2.52B	3.03B	2.21B	2.84B	3.04B	2.42B	1.73B
Other Current Assets	n/a	6B	6.55B	415.06M	4.64B	4.11B	3.48B	337.53M
Total Current Assets	26.74B	23.62B	24.88B	18.88B	15.32B	13.78B	11.39B	7.55B
Property-Plant & Equipment	11.64B	10.82B	11.7B	10.59B	10.38B	7.2B	6.05B	5.32B
Goodwill & Intangibles	2.43B	2.34B	939.25M	958.84M	1.69B	945.86M	187.94M	171.04M
Total Long-Term Assets	19.54B	17.56B	17.62B	16.78B	14.12B	9.39B	6.61B	5.67B
Total Assets	46.28B	41.18B	42.5B	35.65B	29.44B	22.69B	18B	13.22B
Account Payables	2.84B	1.77B	1.62B	1.24B	1.43B	3.27B	1.3B	1.09B
Deferred Revenue	-8.31M	788.16M	524.05M	741.85M	563.5M	795.54M	1.00	1.00
Short-Term Debt	450.22M	291.38M	n/a	265.39M	23M	70.59M	927.28M	897.78M
Other Current Liabilities	486.59M	1.63B	645.75M	1.75B	1.45B	3.91B	2.59B	2.1B
Total Current Liabilities	10.18B	8.83B	8.84B	7.47B	6.98B	7.23B	4.81B	3.66B
Long-Term Debt	n/a	25.42M	n/a	92.88M	n/a	n/a	50M	215.24M
Other Long-Term Liabilities	399.68M	67.04M	12.42M	-75.64M	62.39M	201.9M	153.71M	156.66M
Total Long-Term Liabilities	1.08B	886.28M	534.69M	490.05M	457.11M	439.35M	313.68M	433.56M
Total Liabilities	11.26B	9.72B	9.37B	7.96B	7.43B	7.67B	5.13B	4.09B
Total Debt	706.9M	574.32M	115.04M	375.51M	209.78M	70.45M	824.82M	1.02B
Common Stock	11.99B	10.75B	13.33B	12.92B	12.19B	11.35B	10.8B	9.46B
Retained Earnings	26.46B	20.84B	21.13B	15.79B	10.86B	9.37B	7.04B	5.27B
Comprehensive Income	n/a	-1.73B	-2.57B	-2.12B	-2.28B	-2.8B	-2.3B	-1.88B
Shareholders Equity	30.07B	29.77B	31.79B	26.48B	20.65B	15.02B	12.8B	9.05B
Total Investments	5.72B	7.25B	6.18B	6.48B	3.89B	896.76M	356.57M	153.85M